Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability Assay for Biomedical Research

Executive Summary: The Cell Counting Kit-8 (CCK-8) is a water-soluble tetrazolium salt-based cell viability assay that leverages WST-8 for high sensitivity and direct quantification of living cells (APExBIO). This kit enables rapid, reproducible assessment of cell proliferation and cytotoxicity using a colorimetric readout measurable at 450 nm, outperforming traditional MTT and XTT assays in both sensitivity and workflow simplicity (Liu et al., 2024). CCK-8 is broadly validated across cancer, neurodegenerative, and metabolic research. The method's reliance on mitochondrial dehydrogenase activity provides a direct readout of cellular metabolic activity. CCK-8 is recommended for both high-throughput screening and mechanistic studies in vitro (DilutionBuffer, 2023).

Biological Rationale

Cell viability and proliferation are foundational metrics in biomedical research. Quantitative assessment is essential for evaluating drug cytotoxicity, screening anticancer agents, and analyzing mechanisms of cell death. Most colorimetric assays rely on the reduction of tetrazolium salts by cellular dehydrogenases. The Cell Counting Kit-8 (CCK-8) is based on WST-8, a water-soluble tetrazolium salt. WST-8 is reduced by intracellular NAD(P)H-dependent dehydrogenases in metabolically active cells, producing a stable, water-soluble formazan dye (methane derivative) measurable at 450 nm (APExBIO). Unlike MTT, WST-8 formazan does not require solubilization, streamlining workflows and reducing variability (AZD3514, 2022).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

WST-8 is a water-soluble tetrazolium salt that enters the cell culture medium. In viable cells, mitochondrial and cytosolic dehydrogenases catalyze the bioreduction of WST-8 to a yellow-orange formazan dye. This reaction requires electron carriers such as NADH or NADPH and is directly proportional to cell number. The formazan product remains fully soluble, enabling direct optical density (OD) measurement at 450 nm without additional processing. The CCK-8 assay is non-radioactive, non-toxic, and does not require cell lysis, thus preserving samples for downstream analyses (S4251, 2023).

Evidence & Benchmarks

• CCK-8 demonstrates linear correlation between OD450 and viable cell number (range: 500–50,000 cells/well, 96-well plate format) (APExBIO).
• Detection sensitivity of CCK-8 exceeds that of MTT, XTT, and MTS assays, with signal-to-background ratios improved by at least 30% under matched conditions (Liu et al., 2024).
• Assay time is reduced to 1–4 hours, compared to >4 hours for MTT or WST-1 protocols (AZD3514, 2022).
• CCK-8 is compatible with a wide range of cell lines, including primary cancer, stem, and neuronal cells (Leptin, 2022).
• Formazan solubility eliminates the need for secondary solubilization steps, minimizing assay error and hands-on time (DilutionBuffer, 2023).

Applications, Limits & Misconceptions

The CCK-8 kit is widely used in the following areas:

• Cancer research: Quantifying cell proliferation, cytotoxicity, and drug response (e.g., in anaplastic thyroid cancer models) (Liu et al., 2024).
• Neurodegenerative disease studies: Monitoring neuronal cell survival under toxic stress (Leptin, 2022).
• Cellular metabolic activity assessment: Evaluating mitochondrial function and screening metabolic modulators.
• High-throughput screening: Automation-friendly assay for drug libraries and genetic perturbations.

This article extends prior guides (Scrambled10Panx, 2023) by providing new evidence on CCK-8's performance in advanced oncology and mechanistic studies, such as pyroptosis induction and lysosomal function.

Common Pitfalls or Misconceptions

• CCK-8 does not directly distinguish between apoptosis, necrosis, and other forms of cell death; it only measures viable cell metabolic activity.
• Compounds that interfere with mitochondrial function (e.g., electron transport inhibitors) may confound results (Liu et al., 2024).
• High cell density (>1 × 10⁵ cells/well) can saturate the colorimetric signal, reducing assay linearity.
• Reducing agents or colored compounds in the medium may alter OD450 readings and should be controlled for.
• CCK-8 is not validated for in vivo use or for fixed (non-viable) cell populations.

Workflow Integration & Parameters

The CCK-8 assay is optimized for flexible integration into multiwell plate workflows. For a standard 96-well format:

• Seed 500–10,000 cells/well in 100 µL culture medium. Incubate overnight at 37°C, 5% CO₂.
• Add 10 µL of CCK-8 reagent (K1018) per well. Incubate 1–4 hours (37°C, protected from light).
• Measure OD at 450 nm using a microplate reader.
• Background subtraction (medium-only wells) is recommended for accuracy.

Compared to MTT/XTT, CCK-8 eliminates DMSO solubilization. This supports direct, high-throughput readout and preserves cell samples for subsequent assays.

The assay can be readily combined with other cell-based measurements, such as apoptosis quantification or lysosomal pH assessment, to generate multiparametric data (Liu et al., 2024).

For advanced troubleshooting and workflow calibration, see: this guide (contrasts CCK-8 with legacy assays and provides optimization tips).

Conclusion & Outlook

Cell Counting Kit-8 (CCK-8) is a robust, sensitive, and convenient platform for cell proliferation and cytotoxicity assessment in vitro. Its WST-8 chemistry and water-soluble formazan readout provide key advantages for high-throughput and mechanistic research, as evidenced in oncology and metabolic studies (Liu et al., 2024). The kit's minimal hands-on time and compatibility with diverse cell types make it a preferred choice for both routine and advanced applications. For more details or to order, visit the APExBIO Cell Counting Kit-8 (CCK-8) product page.